<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Recurrent thrombo-embolism represents by far the commonest cause of cerebral and <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In an open clinical study, experience with a largely general anticoagulation in the <z:hpo ids='HP_0011009'>acute</z:hpo> phase of cerebral and <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> is reported </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: From October 1993 to October 1996, 781 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> were admitted to the medical emergency ward </plain></SENT>
<SENT sid="3" pm="."><plain>Taking contra-indications into consideration and after CT exclusion of cerebral haemorrhage (2%) </plain></SENT>
<SENT sid="4" pm="."><plain>Immediate therapeutic heparinisation (1.5-2-fold prolongation of aPTT) was administered to 664 patients (85%) over 7-10 days </plain></SENT>
<SENT sid="5" pm="."><plain>In a concurrent Doppler/duplex comparative study, 143 patients with <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:mp ids='MP_0006134'>artery occlusion</z:mp> were investigated for the prevalence of potential sources of emboli in the region of the extracranial carotids and internal carotid circulation respectively </plain></SENT>
<SENT sid="6" pm="."><plain>108 patients served as a reference group whose <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0000572'>loss of vision</z:hpo> of vascular origin could be attributed to <z:chebi fb="46" ids="15035">retinal</z:chebi> vein <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The complication rate of anticoagulation in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0917798" disease_type="Disease or Syndrome" abbrv="">cerebral ischaemia</z:e> was 0.8% (major complications), and the recurrence rate during the period of treatment was 2.4% </plain></SENT>
<SENT sid="8" pm="."><plain>In 131 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e>, therapeutic heparinisation was performed without ocular cerebral or extracerebral complications </plain></SENT>
<SENT sid="9" pm="."><plain>Potential ipsilateral sources of emboli (highgrade <z:hpo ids='HP_0100546'>carotid stenosis</z:hpo> or complex plaques with thrombotic deposits) were found in 55%, but in only 7% of the control group (p &lt; 0.0001) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Immediate anticoagulation in the form of aPTT-monitored therapeutic heparinisation represents a rational and low-risk concept for the treatment of <z:hpo ids='HP_0011009'>acute</z:hpo> cerebral and <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischaemia</z:e> </plain></SENT>
</text></document>